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ABSTRACT
Gonadotropin-releasing hormone (GnRH) neurons regulate puberty
onset and sexual reproduction by secreting GnRH to activate and
maintain the hypothalamic-pituitary-gonadal axis. During embryonic
development, GnRH neurons migrate along olfactory and
vomeronasal axons through the nose into the brain, where they
project to the median eminence to release GnRH. The secreted
glycoprotein SEMA3A binds its receptors neuropilin (NRP) 1 or NRP2
to position these axons for correct GnRH neuron migration, with an
additional role for the NRP co-receptor PLXNA1. Accordingly,
mutations in SEMA3A, NRP1, NRP2 and PLXNA1 have been
linked to defective GnRH neuron development in mice and inherited
GnRH deficiency in humans. Here, we show that only the combined
loss of PLXNA1 and PLXNA3 phenocopied the full spectrum of nasal
axon andGnRH neuron defects of SEMA3A knockout mice. Together
with Plxna1, the human orthologue of Plxna3 should therefore be
investigated as a candidate gene for inherited GnRH deficiency.
KEYWORDS: GnRH neuron, Olfactory bulb, Testes, Axon guidance,
Plexin, Semaphorin, Hypogonadotropic hypogonadism, Kallmann
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INTRODUCTION
GnRH-secreting neurons are hypothalamic neuroendocrine cells
that regulate sexual reproduction in mammals by stimulating the
pituitary secretion of the gonadotropins luteinizing hormone (LH)
and follicle-stimulating hormone (FSH) (Merchenthaler et al.,
1984). GnRH deficiency is the common hallmark of two genetic
reproductive disorders, hypogonadotropic hypogonadism (HH) and
Kallmann syndrome (KS), which can be due to defective GnRH
neuron development (Boehm et al., 2015; Stamou and
Georgopoulos, 2018).
A key period in GnRH neuron development is their migration
from the nasal placode, where they are born, to their final positions
in the hypothalamus. In the nasal compartment, GnRH neurons
migrate along the intermingled axons of olfactory (OLF) and
vomeronasal (VN) neurons, the cell bodies of which are located in
the nasal placode-derived olfactory epithelium (OE) and
vomeronasal organ (VNO), respectively (Fig. S1A). To enter the
brain, GnRH neurons migrate along the caudal branch of the VN
(cVN) nerve, also known as the cranial nerve 0 or terminal nerve
(Taroc et al., 2017; Yoshida et al., 1995). The axons in this transient
nerve turn caudo-ventrally into the brain at the level of the
cribriform plate (CP), which separates the brain from the nasal
compartment (Taroc et al., 2017) (Fig. S1A). Instead, other VN and
OLF axons project to the main and the accessory olfactory bulb
(OB), respectively (Fig. S1A). Finally, GnRH neurons settle in the
medial preoptic area (MPOA) of the postnatal hypothalamus to
project to the median eminence (ME), where they act as
neuroendocrine cells to release GnRH into the hypophyseal portal
circulation (Wierman et al., 2011) (Fig. S1B). Accordingly, GnRH
neurons can be identified in several distinct compartments of the
embryonic head that reflect their migratory route (Fig. S1C).
The importance of proper axon scaffolds for GnRH neuron
migration is illustrated by the analysis of a human foetus with a KS
mutation; in this foetus, GnRH neurons accumulated in neural
tangles in the meninges at the level of CP (Schwanzel-Fukuda et al.,
1989). Mice lacking the axon guidance cue SEMA3A similarly
accumulate GnRH neurons within axon tangles at the CP and are
therefore hypogonadal (Cariboni et al., 2011). Moreover, they have
a defective olfactory system, with many aberrant OLF axons
(Schwarting et al., 2004). Agreeing with combined GnRH neurons
and olfactory defects in mice lacking SEMA3A, SEMA3A
mutations were subsequently identified in a subset of individuals
with KS (Hanchate et al., 2012; Young et al., 2012). These findings
support the idea that proper axon guidance is essential to ensure
GnRH neuron migration through the nose and into the brain.
Moreover, these findings identify mouse models as powerful tools
for uncovering genes that regulate GnRH neuron development
and may be mutated in individuals with inherited GnRH
neuron deficiency.
To exert its functions, SEMA3A usually binds to
transmembrane receptors composed of a ligand binding subunit
that is either neuropilin (NRP) 1 or NRP2, and a signal transducing
subunit, typically a member of the A-type plexin (PLXNA) family
(Alto and Terman, 2017). Accordingly, mice lacking SEMA3A
signalling through NRP1 and NRP2 have similar axon and GnRH
neuron defects to mice lacking SEMA3A (Cariboni et al., 2011).
Mutations in NRP1, NRP2 and PLXNA1 have also been found in
individuals with KS (Kotan et al., 2019; Marcos et al., 2017),
although PLXNA1 loss affects the GnRH neuron and olfactory
systems in mice only mildly (Marcos et al., 2017). These findings
raise the possibility that PLXNA1 acts in partial redundancy with
another A-type plexin. Here, we have compared the expression
pattern of all four Plxna genes during GnRH neuron development
in the mouse and examined whether Plxna1 synergises with
Plxna3 during nasal axon guidance required for proper GnRH
neuron migration.Received 16 February 2019; Accepted 27 September 2019
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RESULTS AND DISCUSSION
PLXNA1 and PLXNA3 are co-expressed during GnRH neuron
migration
To establish which of the four Plxna genes is expressed in a
pattern consistent with a role in guiding the axons that ensure
GnRH neuron migration, we performed in situ hybridisation of
sections through the wild-type mouse embryo nose. Agreeing
with prior reports (Marcos et al., 2017; Murakami et al., 2001;
Suto et al., 2003), Plxna1 was expressed at E12.5 and E14.5 in
both the VNO and OE, and Plxna3 had a similar expression
pattern (Fig. S2A,B). Additionally, Plxna1 and Plxna3 transcripts
were detected in the migratory mass (MM) (Fig. S2A), a mixed
population of cells that includes neurons and olfactory
ensheathing cells (OECs) (Miller et al., 2010). In contrast,
Plxna2 and Plxna4 appeared only weakly expressed in the VNO,
OE or MM cells (Fig. S2A). We therefore focussed subsequent
work on Plxna1 and Plxna3.
To determine which cell types expressed PLXNA1 or PLXNA3
in the territories relevant to GnRH neuron migration, we
immunostained sections through wild-type mouse embryo heads.
Double labelling with the TUJ1 antibody for neuronal-specific β3
tubulin (nTUBB3) showed that PLXNA1 and PLXNA3 localised to
the MM at E12.5 and to axons emerging from the OE and VNO at
E12.5 and E14.5 (Fig. 1A,B). Double labelling for the OECmarker
S100 showed that OECs lacked PLXNA1 and PLXNA3, but that
they surrounded PLXNA1/PLXNA3 double-positive axons
(Fig. 1C,D). Immunostaining of Plxna1−/− and Plxna3−/− mouse
tissues validated antibody specificity (Fig. 1E). Double labelling for
peripherin (PRPH), a marker of OLF and VN, including cVN axons
(Fueshko and Wray, 1994; Taroc et al., 2017), confirmed that both
PLXNs localised to E14.5 nasal axons; PLXNA1 was also
prominent on cVN axons in the forebrain, whereas PLXNA3
staining of cVN axons was undetectable (Fig. 2). A prior study
reported PLXNA1 immunostaining of E12.5 GnRH neurons
(Marcos et al., 2017); in agreement, we observed low Plxna1
transcript levels in FACS-isolated E13.5 GnRH neurons (Cariboni
et al., 2007). Nevertheless, GnRH neurons in the E14.5 nose and
ventral forebrain lacked obvious PLXNA1 or PLXNA3 protein
(Fig. 2).
Together, these findings raise the possibility that PLXNA1 and
PLXNA3 pattern the axons that guide GnRH neurons, either
directly or by regulating the behaviour of pioneer cells in the MM
that act as guide-post cells for the first nasal axons (Miller et al.,
2010). Additionally, GnRH neurons may themselves express
PLXNA1 for some time during their development.
ReducedGnRHneuronmigration into the forebrain ofPlxna1/
Plxna3-null embryos
We next investigated whether combined loss of PLXNA1 and
PLXNA3 impairs GnRH neuron migration more severely than loss
of PLXNA1 alone. Thus, we analysed the number and position of
GnRH neurons in embryos from parents carrying Plxna1-null and
Plxna3-null alleles (Cheng et al., 2001; Yoshida et al., 2006). GnRH
immunostaining showed that Plxna1−/− and Plxna3−/− single as
well as Plxna1−/−; Plxna3−/− double mutants had an overall
similar number of GnRH neurons compared with wild-type
littermates at E14.5 (Fig. 3A,C and Table S1). Whereas Plxna1−/−
and Plxna3−/− single mutants had a similar number of neurons as
wild types in the forebrain, Plxna1−/−; Plxna3−/− double mutants
contained significantly fewer GnRH neurons in the forebrain
(Fig. 3A,C and Table S1). The loss of GnRH neurons from the
brain of Plxna1−/−; Plxna3−/− double mutants was explained by
the statistically significant retention of GnRH neurons in the
nose, including at the CP (Fig. 3B,C and Table S1).
Similar results were obtained by Gnrh in situ hybridisation
(Fig. S3A). As the overall number of GnRH neurons was
similar in all these genotypes at this stage, the primary GnRH
neuron defect in double mutants is likely the impaired
forebrain entry.
Combined PLXNA1 and PLXNA3 loss increases morbidity
and causes GnRH neuron, gonadal and olfactory system
defects
To assess whether lack of GnRH neurons in the forebrain of E14.5
Plxna1−/−; Plxna3−/− embryos results in an hypogonadal state in
adulthood, we analysed postnatal Plxna1−/−; Plxna3−/− mice. The
analysis of five litters from parents with combined Plxna1-null and
Plxna3-null alleles suggested that all genotypes were born at a
normal Mendelian ratio (Table S2), but there was a high rate of pre-
weaning mortality. As the Plxna3 gene resides on the X
chromosome, males in these litters are either wild type or
hemizygous for the Plxna3-null mutation, i.e. Plxna3y/+ or
Plxna3y/−, respectively. In contrast, females are Plxna3+/+,
Plxna3+/− or Plxna3−/−. Pooled male and female mice lacking
Plxna3 are therefore referred to as Plxna3−/−(y). We found that two
out of five juvenile Plxna1−/−; Plxna3−/−(y) mutants were small and
appeared stressed when handled and had to be culled before
weaning to prevent suffering. To avoid the birth of further mutants
with such severe adverse effects, breeding was concluded and all
mutants obtained were culled for analyses.
We next compared the GnRH neuron number in the MPOA of
postnatal mutants and wild-type controls, because this is the final
position most neurons should attain. Whereas the GnRH neuron
number in the Plxna3y/− MPOA was similar to that of wild-type
littermates, three out of five Plxna1−/− mutants had slightly fewer
and four out of four Plxna1−/−; Plxna3−/−(y) mutants contained
hardly any GnRH neurons in the MPOA (Fig. 3D,E and Table S3).
Agreeing with a severely reduced GnRH neuron number, GnRH
staining of the ME was nearly absent in Plxna1−/−; Plxna3−/−(y)
mutants (Fig. 3F), despite normal hypothalamic projections of other
neuroendocrine neurons, such as those that secrete the corticotropin-
releasing hormone CRH (Fig. S3B). Moreover, overall brain size
was similar in all genotypes (Table S4). All genotypes also had
similar OB sizes (Table S4), but Plxna1−/−; Plxna3−/−(y) mutants
had a smaller glomerular layer (GL) in the dorso-lateral OB
compared with single mutants or wild types (Fig. S4). Accordingly,
the combined loss of PLXNA1 and PLXNA3 causes defects in both
the GnRH neuron and olfactory systems: the two co-existing
hallmarks of KS.
Consistent with hypothalamic GnRH deficiency, three out of
three Plxna1−/−; Plxna3−/−(y) mutants had smaller gonads
compared with single mutant littermates and wild types (two out
of two males lacking both PLXNA1 and PLXNA3 had smaller
testes and seminiferous vesicles, and one out of one female lacking
both PLXNA1 and PLXNA3 had smaller ovaries; Fig. 3G-H;
Fig. S5A,B). Notably, one out of two Plxna1−/−; Plxna3y/− males
examined had only one testis (Fig. S5A) and double mutant testes
appeared immature and contained hardly any spermatids (Fig. S5C).
We also detected PLXNA1 (Perälä et al., 2005) and PLXNA3
expression in the seminiferous tubules and interstitial cells of the
testes, but not in the ovary or pituitary (Fig. S5D-F). Thus, the
severe testes phenotype of double mutants may result from the
combined tissue-specific loss of both plexins and hypothalamic
GnRH deficiency.
2
RESEARCH REPORT Development (2019) 146, dev176461. doi:10.1242/dev.176461
D
E
V
E
LO
P
M
E
N
T
A prior study reporting KS-like symptoms in adult Plxna1−/−
mice had focussed on the analysis of males (Fig. 3 in Marcos et al.,
2017). As we observed a genetic interaction of Plxna1 and Plxna3,
it is conceivable that the mild and only partially penetrant defect
observed in Plxna1−/−males might be explained, at least in part, by
the hemizygous state of Plxna3 in males that impacts on GnRH
neuron development. However, it is not known whether Plxna3
hemizygosity contributes to the increased incidence of KS in males
Fig. 1. Expression of PLXNA1 and PLXNA3 on neuronal cell bodies and axons. (A,B) Expression of PLXNA1 and PLXNA3 on neurons and axons. Coronal
sections of E12.5 (A) and E14.5 (B) mouse heads were immunolabelled at the level of the VNO for nTUBB3 together with PLXNA1 or PLXNA3. The
corresponding single PLXNA1 or PLXNA3 channels are shown below each image. White boxes indicate areas shown at higher magnification on the right. Arrows
and arrowheads indicate examples of PLXNA1- and PLXNA3-positive neurons and axons, respectively. (C,D) PLXNA1 and PLXNA3 are not expressed by S100-
positive cells. Coronal sections of E12.5 (C) and E14.5 (D) mouse heads at VNO level were immunolabelled for S100 to detect OECs and PLXNA1 or PLXNA3.
White boxes indicate areas shown at higher magnification on the right of the corresponding panel. Open arrowheads indicate lack of PLXNA1 or PLXNA3
colocalisation with S100. (E) Specificity of PLXNA1 and PLXNA3 antibodies. Coronal sections from E14.5 Plxna1- and Plxna3-null mice at VNO level were
immunostained for PLXNA1 or PLXNA3; lack of staining indicates antibody specificity. All sections were counterstained with DAPI. OE, olfactory epithelium;
OB, olfactory bulb; NS, nasal septum; VNO, vomeronasal organ. Scale bars: 150 or 50 μm for lower and higher magnifications, respectively.
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compared with females. Notably, two out of two adult Plxna1−/−;
Pxna3+/− females had a severe reduction of GnRH neurons in the
MPOA, which exceeded that seen in three out of five Plxna1−/−
male mutants (Table S3). The intermediate phenotype severity in
these females between Plxna1−/− single and Plxna1−/−; Pxna3y/−
double mutants may be explained by random X-chromosome
inactivation, as this has the potential to remove the functional copy
of PLXNA3 in Pxna3+/− females and thereby decrease PLXNA3
dose. Further work would be required to investigate this hypothesis.
Mispatterned OLF/VN axons in Plxna1/Plxna3-null embryos
form axon tangles at the cribriform place that retain GnRH
neurons
To better understand the underlying cause of abnormal GnRH neuron
migration during embryogenesis, we examined the patterning of their
PRPH+ axonal migratory scaffolds in E14.5 embryos from parents
carrying bothPlxna1- andPlxna3-null alleles. Thiswas also important,
because nasal axon defects were previously reported in five out of 18
E14.5Plxna1−/−mutants (Marcos et al., 2017).We found that three out
of three Plxna1−/− and three out of three Plxna3−/− single mutants had
similar PRPH+ axon organisation as wild-type littermates, whereas
three out of three Plxna1−/−; Plxna3−/− double mutants contained
PRPH+mistargeted axons between theOBs and axon tangles at theCP
(Fig. 4A,B). These axon defects therefore occur in areas in which
GnRH neurons accumulate (Fig. 4B; see also Fig. 3B). Even though
cVN axons emerged from the VNO in all genotypes analysed
(Fig. S6A), double mutants lacked cVN axons in the forebrain
(Fig. 4A,B). Moreover, double, but not single null mutants, had
defasciculated and enlarged OLF axon bundles below the ventro-
medial OBs (Fig. S6B) that may explain the small size of the
glomerular layer (GL) in the OB of double-null mutants (see Fig. S4).
In summary, the combined loss of PLXNA1 and PLXNA3
severely disrupts the axons that guide GnRH neurons through the
nose and into the brain, and additionally impairs olfactory
development. Notably, the axonal defects are similar to those
reported for Sema3a-null mutants (Cariboni et al., 2011; Hanchate
et al., 2012), supporting the idea that PLXNA1 and PLXNA3 serve as
co-receptors for SEMA3A during VN and OLF axon development.
Interestingly, partial PLXNA redundancy for SEMA3A-mediated
axon targeting mirrors the redundancy for SEMA3A ligand-binding
Fig. 2. PLXNA1 and PLXNA3 localise to nasal axons. (A-D) Coronal sections of E14.5 mouse heads were immunolabelled for PLXNA1 (A,B) or PLXNA3 (C,D)
together with PRPH (top panels) or GnRH (bottom panels). Sections are shown at the level of the VNO (nose) or MPOA (forebrain). White boxes indicate areas
shown at higher magnification on the right of the corresponding panel, with single channels shown also adjacent to the panel. Arrowheads in A-C indicate
examples of PRPH-positive axons with PLXNA1 and PLXNA3. Open arrowheads in D indicate examples of PRPH-positive axons that lack PLXNA3. Open arrows
in A-D indicate examples of GnRH neurons that lack PLXNA1 and PLXNA3. All sections were counterstained with DAPI. OE, olfactory epithelium; OB, olfactory
bulb; VNO, vomeronasal organ; MPOA, medial preoptic area. Scale bars: 150 or 50 μm for lower and higher magnifications, respectively.
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receptors, as loss of semaphorin signalling through both NRP1 and
NRP2 is required to elicit the full spectrum ofVN and OLF, as well as
the GnRH neuron migration defects that are observed in Sema3a-null
mutants (Cariboni et al., 2007, 2011).
Conclusions
Here, we show that PLXNA1 and PLXNA3 cooperate to pattern
the SEMA3A/NRP-dependent axons that serve as migratory
scaffolds for GnRH neurons en route from the nasal placodes to
the brain, and also contribute to olfactory axon patterning.
Accordingly, the loss of both PLXNA1 and PLXNA3 from nasal
axons impairs the development of the GnRH neuron and
olfactory systems to cause a KS-like phenotype in adult mice
(see working model, Fig. 4C). The human orthologue of Plxna3,
like PLXNA1, should thus be considered a candidate gene for
mutation screening in individuals with KS. We further observed
Fig. 3. Combined PLXNA1 and PLXNA3 loss decreases GnRH neuron number, ME innervation and testes size in adult mice. (A-C) Embryonic
GnRH neuron analysis. (A) Coronal sections of E14.5 mouse heads with the indicated genotypes were immunolabelled for GnRH. The OB boundaries are
indicated with black dotted lines in the wild-type panel. Arrowheads indicate examples of GnRH neurons at the CP (top panels), in the nasal parenchyma (middle
panels) and in the MPOA (bottom panels). The black arrow and open arrowheads indicate GnRH neuron clumps between the OBs and at the CP, respectively.
Δ indicates a lack of GnRH neurons in the MPOA. (B) High-magnification image of a double mutant E14.5 embryo showing an example of GnRH neurons
accumulating at the CP and between OBs. (C) Quantification of GnRH neuron number in the E14.5 head; data are mean±s.d.; ***P<0.001, **P<0.01, *P<0.05
(one-way ANOVAwith Dunnett’s test). (D-F) Adult GnRH neuron analysis. Coronal sections of P60 brains with the indicated genotypes at the level of the MPOA
(D) and ME (F) were immunolabelled for GnRH. Δ indicates a lack of GnRH staining. (E) Quantification of GnRH neuron number in the P60 MPOA;
data are mean±s.d.; *P<0.05, ****P<0.0001 (one-way ANOVA with Dunnett’s test). (G,H) Adult gonad size. Micrographs show paired testes (G, left panel),
seminal vesicles (G, right panel) and ovaries (H) of P60 littermate mice. OB, olfactory bulb; CP, cribriform plate; MPOA, medial preoptic area; ME, median
eminence; sem. ves., seminal vesicles. Scale bars: 150 μm in A,F; 100 μm in B; 250 μm in D; 3mm in G; 1.5 mm in H.
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severe defects in testes formation in PLXNA1 and PLXNA3
mice that exceed those seen in KS, suggesting that these genes
might also be mutated in other congenital diseases that affect
gonad formation.
MATERIALS AND METHODS
Mouse strains
Mice lacking Plxna1 or Plxna3 (Cheng et al., 2001; Yoshida et al., 2006)
were used in a C57/Bl6 background for all embryonic studies or on a CD1
Fig. 4. Combined PLXNA1 and PLXNA3 loss impairs nasal axon and GnRH neuron distribution. (A,B) Adjacent coronal sections of E14.5 mouse heads of
the indicated genotypes at the level of the CP (A) and MPOA (B) were immunolabelled for PRPH to reveal OLF, VN and cVN axons (top panels) and GnRH
neurons (bottom panels). The OB boundaries are indicated with dotted lines in the wild-type panel. Solid arrows and open arrowheads indicate examples of
ectopic axons and GnRH neurons between the OBs and at the CP, respectively. Solid arrowheads indicate cVN axons in theMPOA. A lack of GnRH neurons and
cVN axons in the MPOA is indicated with Δ. OB, olfactory bulb; CP, cribriform plate; MPOA, medial preoptic area. Scale bars: 150 μm. (C) Working model
summarising the observed defects in GnRH neuron (green) migration and axon organisation in wild-type embryos versus SEMA3A pathway mutants. Normal
axon projections are shown as continuous black lines, abnormal projections are shown as continuous red lines; the interrupted red line in mutants represents
the missing cVN branch. The corresponding predicted signalling pathways are shown adjacent to each head schematic.
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background to increase postnatal survival of double mutants. As the Plxna3
gene resides on the X chromosome, we have indicated whether postnatal
mice were male (Plxna3y/−) or female (Plxna3−/−), and have referred to
groups of both sexes as Plxna3−/−(y); the sex of mouse embryos was not
determined, and we therefore refer to all embryos lacking PLXNA3 as
Plxna3−/−. To obtain mouse embryos of defined gestational ages, mice were
mated in the evening, and the morning of vaginal plug formation was
counted as embryonic day (E) 0.5. Owing to the severe phenotype in five out
of five postnatal double mutants in the five litters obtained, we abandoned
further crosses to obtain additional adult mutants due to ethical
considerations. All animal procedures were performed in accordance with
Animal Welfare Ethical Review Body (AWERB) guidelines and under UK
Home Office licence and Italian Ministry of Health licences.
Tissue preparation and cryosectioning
E12.5 and E14.5 embryos were fixed for 3 h in 4% formaldehyde, whereas
postnatal tissues were dissected after perfusion in 4% formaldehyde. All
samples were then cryoprotected overnight in 30% sucrose, embedded in
OCT and cryosectioned for immunohistochemistry or in situ hybridisation.
Schematic drawings showing the anatomical levels and orientation of the
sections are displayed in Fig. S1A,B.
In situ hybridisation
Formaldehyde-fixed cryosections were incubated with digoxigenin (DIG)-
labelled antisense riboprobes for mouse Plxna1, Plxna2, Plxna3 or Plxna4
(Addgene plasmids 58237, 62353, 58238 and 58239, respectively; Schwarz
et al., 2008) or mouse Gnrh (Cariboni et al., 2015). For labelling, we used
the DIG RNA labelling kit (Roche). Hybridisation was performed in 50%
formamide, 0.3 M sodium chloride, 20 mM Tris (pH 7.5), 5 mM EDTA,
10% dextran sulphate and 1× Denhardt’s solution overnight at 65°C.
Sections were washed in a saline sodium citrate buffer (50% formamide, 1×
saline sodium citrate buffer, 0.1% Tween20), incubated overnight with
alkaline phosphatase (AP)-conjugated anti-DIG IgG (1:1500; Roche) and
developed overnight at 37°C with 4-nitro blue tetrazolium chloride and
5-bromo-4-chloro-3-indolyl phosphate disodium salt (Roche) dissolved in a
buffer comprising 100 mM Tris (pH 9.5), 50 mM MgCl2, 100 mM NaCl
and 1% Tween 20.
Immunofluorescence labelling
Cryostat sections (25 μm) of formaldehyde-fixed embryos were incubated
with serum-free protein block (DAKO) after permeabilisation of sections
with 0.1% TritonX-100. We used as primary antibodies rabbit anti-
peripherin (1:100; Merck Millipore, AB1530), rabbit anti-GnRH,
previously validated to recognise both the pre-hormone and the processed
hormone (Taroc et al., 2019) (1:400; Immunostar, 20075), rabbit anti-S100
(1:400, DAKO, Z0311), mouse anti-TUBB3 (1:500, clone Tuj1, Covance,
MMS- 435P), goat anti-OMP (1:200 WAKO, 019-22291), goat anti-
PLXNA1 (1:200; R&D Systems, AF4309) and goat anti-PLXNA3 (1:200;
R&D Systems, AF4075). Secondary antibodies used were Cy3-conjugated
donkey anti-goat and 488-conjugated donkey anti-rabbit Fab fragments
(1:200; Jackson Immunoresearch). Nuclei were counterstained with DAPI
(1:10,000; Sigma).
Immunoperoxidase labelling
Cryostat sections (25 µm) of formaldehyde-fixed samples were incubated
with hydrogen peroxide to quench endogenous peroxidase activity, and
sequentially incubated with 10% heat-inactivated normal goat serum in PBS
or serum-free blocking solution (DAKO) and then immunostained with the
above antibodies to GnRH (1:1000), PLXNA1 (1:500) and PLXNA3
(1:500) or antibodies to CRH (1:400, Proteintech, cat. no. 10944-1-AP)
followed by an appropriate species-specific biotinylated antibody (1:400;
Vector Laboratories). Sections were developed using the ABC kit (Vector
Laboratories) and 3,3-diaminobenzidine (DAB; Sigma). To determine the
total number of GnRH neurons at E14.5, 25-µm coronal sections through
each entire head were immunolabelled for GnRH, and all GnRH-positive
cells in the nose, CP area and forebrain were counted, as previously reported
(Cariboni et al., 2011, 2015) (Fig. S1C). To help distinguish individual
GnRH neurons found in cell clumps at the CP of double mutants, high-
magnification images were analysed. To determine the number of GnRH
neurons in theMPOA of postnatal adult male brains, 25-µm coronal sections
through theMPOA from a position around 200 µm after the end ofME to the
area in which the two hemispheres separate (60 sections/brain) were
immunolabelled and all GnRH-positive cells counted in all sections.
Haematoxylin and Eosin staining
Sections (8 µm) of formaldehyde-fixed testes from P60 mice were stained as
previously described (Macchi et al., 2017).
Statistical analysis
Sample sizes for expression and mouse phenotyping analyses were
estimated based on prior experience and those in the existent literature.
Typically, embryo samples were taken from at least three different litters for
each group. Randomization was not used to assign samples to experimental
groups or to process data, but samples were allocated to groups based on
genotypes. The researcher analysing the data was blind to the genotypes
during analysis. Loss of sections during cryosectioning of embryo heads,
damaged tissue and unspecific immunostaining were pre-established criteria
for sample exclusion, otherwise all samples were included in the analyses.
All data are expressed as mean±s.d. We used a one-way ANOVA followed
by a Dunnett’s test to determine the statistical significance between values in
multiple comparisons; P<0.05 was considered significant; P<0.05, P<0.01,
P<0.001 or P<0.0001 are indicated with one, two, three or four asterisks,
respectively. Statistical analysis was performed using Prism4 software
(GraphPad Software).
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microscopes.
Competing interests
The authors declare no competing or financial interests.
Author contributions
Conceptualization: R.O., A. Cariboni, C.R.; Methodology: R.O., A. Cariboni;
Formal analysis: R.O., A.P., A. Cariboni; Investigation: R.O., A. Caramello, S.C.,
A.L., E.I., A.F., A. Cariboni; Resources: A. Cariboni, C.R.; Writing - original
draft: A. Cariboni, C.R.; Writing - review & editing: R.O., A. Cariboni, C.R.;
Supervision: A. Cariboni, C.R.; Project administration: A. Cariboni, C.R.; Funding
acquisition: A. Cariboni, C.R.
Funding
This research was funded by the Biotechnology and Biological Sciences Research
Council (BB/L002639/1 to C.R.), by the Fondazione Telethon (GGP13142 to A.C.)
and by the CHARGE Foundation (to A.C.) R.O. received a Boehringer Ingelheim
Fonds travel fellowship.
Supplementary information
Supplementary information available online at
http://dev.biologists.org/lookup/doi/10.1242/dev.176461.supplemental
References
Alto, L. T. and Terman, J. R. (2017). Semaphorins and their signaling mechanisms.
Methods Mol. Biol. 1493, 1-25. doi:10.1007/978-1-4939-6448-2_1
Boehm, U., Bouloux, P.-M., Dattani, M. T., de Roux, N., Dodé, C., Dunkel, L.,
Dwyer, A. A., Giacobini, P., Hardelin, J.-P., Juul, A. et al. (2015). Expert
consensus document: European consensus statement on congenital
hypogonadotropic hypogonadism—pathogenesis, diagnosis and treatment. Nat.
Rev. Endocrinol. 11, 547-564. doi:10.1038/nrendo.2015.112
Cariboni, A., Hickok, J., Rakic, S., Andrews, W., Maggi, R., Tischkau, S. and
Parnavelas, J. G. (2007). Neuropilins and their ligands are important in the
migration of gonadotropin-releasing hormone neurons. J. Neurosci. 27,
2387-2395. doi:10.1523/JNEUROSCI.5075-06.2007
Cariboni, A., Davidson, K., Rakic, S., Maggi, R., Parnavelas, J. G. and
Ruhrberg, C. (2011). Defective gonadotropin-releasing hormone neuron
migration in mice lacking SEMA3A signalling through NRP1 and NRP2:
7
RESEARCH REPORT Development (2019) 146, dev176461. doi:10.1242/dev.176461
D
E
V
E
LO
P
M
E
N
T
implications for the aetiology of hypogonadotropic hypogonadism. Hum. Mol.
Genet. 20, 336-344. doi:10.1093/hmg/ddq468
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Gonadotropin-releasing hormone (GnRH) neurons and pathways in the rat brain.
Cell Tissue Res. 237, 15-29. doi:10.1007/BF00229195
Miller, A. M., Treloar, H. B. and Greer, C. A. (2010). Composition of the migratory
mass during development of the olfactory nerve. J. Comp. Neurol. 518,
4825-4841. doi:10.1002/cne.22497
Murakami, Y., Suto, F., Shimizu, M., Shinoda, T., Kameyama, T. and Fujisawa, H.
(2001). Differential expression of plexin-A subfamily members in the mouse
nervous system. Dev. Dyn. 220, 246-258. doi:10.1002/1097-0177(20010301)
220:3<246::AID-DVDY1112>3.0.CO;2-2
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